XORTX Therapeutics, Inc. (XRTX)
2.39
+0.11
(+4.82%)
USD |
NASDAQ |
Sep 09, 09:58
XORTX Therapeutics Market Cap : 4.136M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 3.946M |
| September 04, 2026 | 3.998M |
| September 03, 2026 | 3.721M |
| September 02, 2026 | 4.292M |
| September 01, 2026 | 3.738M |
| August 31, 2026 | 4.015M |
| August 28, 2026 | 4.046M |
| August 27, 2026 | 4.223M |
| August 26, 2026 | 3.838M |
| August 25, 2026 | 3.911M |
| August 24, 2026 | 3.461M |
| August 21, 2026 | 3.530M |
| August 20, 2026 | 3.496M |
| August 19, 2026 | 3.461M |
| August 18, 2026 | 3.542M |
| August 17, 2026 | 3.565M |
| August 14, 2026 | 3.729M |
| August 13, 2026 | 3.79M |
| August 12, 2026 | 3.740M |
| August 11, 2026 | 3.045M |
| August 10, 2026 | 3.008M |
| August 07, 2026 | 2.966M |
| August 06, 2026 | 2.827M |
| August 05, 2026 | 3.049M |
| August 04, 2026 | 3.008M |
| Date | Value |
|---|---|
| August 03, 2026 | 2.966M |
| July 31, 2026 | 2.952M |
| July 30, 2026 | 2.813M |
| July 29, 2026 | 2.868M |
| July 28, 2026 | 2.854M |
| July 27, 2026 | 2.813M |
| July 24, 2026 | 2.820M |
| July 23, 2026 | 2.924M |
| July 22, 2026 | 2.799M |
| July 21, 2026 | 2.840M |
| July 20, 2026 | 2.799M |
| July 17, 2026 | 2.799M |
| July 16, 2026 | 2.938M |
| July 15, 2026 | 2.799M |
| July 14, 2026 | 2.799M |
| July 13, 2026 | 2.827M |
| July 10, 2026 | 3.028M |
| July 09, 2026 | 2.931M |
| July 08, 2026 | 2.861M |
| July 07, 2026 | 2.840M |
| July 06, 2026 | 2.882M |
| July 02, 2026 | 2.882M |
| July 01, 2026 | 2.952M |
| June 30, 2026 | 3.022M |
| June 29, 2026 | 3.063M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lexaria Bioscience Corp. | 13.89M |
| InMed Pharmaceuticals, Inc. | 4.342M |
| Target Group, Inc. (Canada) | 0.6787M |
| NervGen Pharma Corp. | 231.98M |
| Milestone Pharmaceuticals, Inc. | 141.93M |
Market Cap Related Metrics
| PEG Ratio | -0.0191 |
| Price to Book Value | 0.7514 |
| Price | 2.39 |
| Earnings Yield | -114.8% |
| PEGY Ratio | -0.0191 |